Early Efficacy of Ferric Carboxymaltose (Ferinject®) in Patients with Iron-Deficiency Anemia: Single Institution Experience

被引：0
|
作者：
Kerbage, Fouad [1 ,2 ,3 ]
Sakr, Riwa [2 ,3 ]
Akoury, Elie [2 ,3 ]
Eid, Anthony [2 ,3 ]
Chahine, Georges [2 ,3 ]
Massoud, Marcel [2 ,3 ]
机构：
[1] Inst Gustave Roussy, Hematol Dept, Villejuif, France
[2] Holy Spirit Univ Kaslik, Jounieh, Lebanon
[3] UHC Notre Dame Secours, Jbeil, Lebanon
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Ferric Carboxymaltose; Early Efficacy; Iron Deficiency Anemia;
D O I：
10.1016/j.clml.2018.07.245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RES-056
引用
收藏
页码：S296 / S297
页数：2
相关论文
共 50 条
  • [41] Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia Two Randomized Clinical Trials
    Wolf, Myles
    Rubin, Janet
    Achebe, Maureen
    Econs, Michael J.
    Peacock, Munro
    Imel, Erik A.
    Thomsen, Lars L.
    Carpenter, Thomas O.
    Weber, Thomas
    Brandenburg, Vincent
    Zoller, Heinz
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (05): : 432 - 443
  • [42] Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia
    Breymann, Christian
    Gliga, Flaviu
    Bejenariuc, Christina
    Strizhova, Nina
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 101 (01) : 67 - 73
  • [43] The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease
    Koduru, Pramoda
    Abraham, Bincy P.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (01) : 76 - 85
  • [44] EFFICACY AND SAFETY OF INTRAVENOUS FERRIC CARBOXYMALTOSE IN CHILDREN WITH IRON DEFICIENCY ANEMIA UNRESPONSIVE TO ORAL IRON THERAPY
    Powers, Jacquelyn
    Shamoun, Mark
    Buchanan, George
    McCavit, Timothy
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 38 - 38
  • [45] Efficacy and Safety of Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Unresponsive to Oral Iron Therapy
    Powers, Jacquelyn M.
    Shamoun, Mark P.
    McCavit, Timothy L.
    Adix, Leah
    Buchanan, George R.
    BLOOD, 2015, 126 (23)
  • [46] Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients
    Taha, Amira Mohamed
    Elsaeidy, Ahmed Saad
    Nada, Sarah A.
    Sharma, Sadish
    Ghonaim, Mohamed M.
    Ahsan, Areeba
    Mourid, Marina Ramzy
    Abouelmagd, Khaled
    CLINICAL DRUG INVESTIGATION, 2024, 44 (12) : 879 - 896
  • [47] Efficacy and safety of a restrictive ferric carboxymaltose infusion strategy for iron deficiency anemia in inflammatory bowel disease patients
    Crispino, F.
    Grova, M.
    Maida, M.
    Renna, S.
    Casa, A.
    Rizzo, G.
    Macaluso, F. S.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S292 - S292
  • [48] FERRIC CARBOXYMALTOSE DESENSITIZATION IN REFRACTORY IDIOPATHIC IRON-DEFICIENCY ANEMIA, IRON-INFUSION ANAPHYLAXIS, SEVERE ATOPY AND HYPERTRYPTASEMIA
    Joseph, M.
    Szafron, V.
    Yang, B.
    Srivaths, L.
    Anvari, S.
    Castells, M.
    Noroski, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S70 - S70
  • [49] Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia
    Bae, Hyoeun
    Cho, Yong Won
    Kim, Keun Tae
    Li, Xu
    Earley, Christopher J.
    SLEEP MEDICINE, 2023, 109 : 128 - 131
  • [50] Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy
    Carla Rognoni
    Vittorio Ortalda
    Caterina Biasi
    Giovanni Gambaro
    Advances in Therapy, 2019, 36 : 3253 - 3264
12345